Refractory atrial fibrillation effectively treated with ranolazine

Atrial fibrillation is the most common sustained cardiac arrhythmia which is often troublesome to manage. Currently, rhythm and rate control medications are the mainstays of therapy. In 2 amiodarone-refractory highly symptomatic patients, an innovative approach using ranolazine, which selectively ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaishnav, Aditi, Vaishnav, Avani, Lokhandwala, Yash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946441/
https://www.ncbi.nlm.nih.gov/pubmed/24581108
http://dx.doi.org/10.1016/j.ihj.2013.12.024
_version_ 1782306648422875136
author Vaishnav, Aditi
Vaishnav, Avani
Lokhandwala, Yash
author_facet Vaishnav, Aditi
Vaishnav, Avani
Lokhandwala, Yash
author_sort Vaishnav, Aditi
collection PubMed
description Atrial fibrillation is the most common sustained cardiac arrhythmia which is often troublesome to manage. Currently, rhythm and rate control medications are the mainstays of therapy. In 2 amiodarone-refractory highly symptomatic patients, an innovative approach using ranolazine, which selectively acts on Na+ channels and delays atrial depolarization, was tried successfully.
format Online
Article
Text
id pubmed-3946441
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-39464412014-03-10 Refractory atrial fibrillation effectively treated with ranolazine Vaishnav, Aditi Vaishnav, Avani Lokhandwala, Yash Indian Heart J Case Report Atrial fibrillation is the most common sustained cardiac arrhythmia which is often troublesome to manage. Currently, rhythm and rate control medications are the mainstays of therapy. In 2 amiodarone-refractory highly symptomatic patients, an innovative approach using ranolazine, which selectively acts on Na+ channels and delays atrial depolarization, was tried successfully. Elsevier 2014 2014-01-04 /pmc/articles/PMC3946441/ /pubmed/24581108 http://dx.doi.org/10.1016/j.ihj.2013.12.024 Text en © 2013, Cardiological Society of India. All rights reserved. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Vaishnav, Aditi
Vaishnav, Avani
Lokhandwala, Yash
Refractory atrial fibrillation effectively treated with ranolazine
title Refractory atrial fibrillation effectively treated with ranolazine
title_full Refractory atrial fibrillation effectively treated with ranolazine
title_fullStr Refractory atrial fibrillation effectively treated with ranolazine
title_full_unstemmed Refractory atrial fibrillation effectively treated with ranolazine
title_short Refractory atrial fibrillation effectively treated with ranolazine
title_sort refractory atrial fibrillation effectively treated with ranolazine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946441/
https://www.ncbi.nlm.nih.gov/pubmed/24581108
http://dx.doi.org/10.1016/j.ihj.2013.12.024
work_keys_str_mv AT vaishnavaditi refractoryatrialfibrillationeffectivelytreatedwithranolazine
AT vaishnavavani refractoryatrialfibrillationeffectivelytreatedwithranolazine
AT lokhandwalayash refractoryatrialfibrillationeffectivelytreatedwithranolazine

Ejemplares similares